Merck KGaA MKGAF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MKGAF is a good fit for your portfolio.
News
-
Merck KGaA FY24 Outlook Improves After Strong Second Quarter
-
Germany's Merck to Sell Surface Solutions Unit For $721 Million
-
Germany's Merck to Buy Unity-SC for at Least $170 Million
-
German Stocks Fall Tuesday
-
Germany's Merck Group shares drop 10% after scrapping trial of promising cancer drug
-
Merck KGaA Shares Drop After Canceled Late-Stage Cancer Drug Study
-
Merck KGaA Signs Korea Science Research Pact
-
Merck KGaA Buys Mirus Bio for $600 Million
Trading Information
- Previous Close Price
- $170.45
- Day Range
- $165.65–177.26
- 52-Week Range
- $143.46–193.63
- Bid/Ask
- $174.35 / $178.60
- Market Cap
- $77.07 Bil
- Volume/Avg
- 65 / 230
Key Statistics
- Price/Earnings (Normalized)
- 22.12
- Price/Sales
- 3.41
- Dividend Yield (Trailing)
- 1.33%
- Dividend Yield (Forward)
- 1.33%
- Total Yield
- 1.33%
Company Profile
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 62,345
- Website
- https://www.emdgroup.com
Competitors
Valuation
|
Metric
|
MKGAF
|
BIIB
|
TMO
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.12 | 14.08 | 28.08 |
Price/Book Value | 2.55 | 2.01 | 4.89 |
Price/Sales | 3.41 | 3.19 | 5.53 |
Price/Cash Flow | 16.28 | 13.16 | 27.23 |
Price/Earnings
MKGAF
BIIB
TMO
Financial Strength
|
Metric
|
MKGAF
|
BIIB
|
TMO
|
|---|---|---|---|
Quick Ratio | 0.72 | 0.95 | 1.19 |
Current Ratio | 1.29 | 2.10 | 1.70 |
Interest Coverage | 10.23 | 5.38 | 4.83 |
Quick Ratio
MKGAF
BIIB
TMO
Profitability
|
Metric
|
MKGAF
|
BIIB
|
TMO
|
|---|---|---|---|
Return on Assets (Normalized) | 5.60% | 8.32% | 8.69% |
Return on Equity (Normalized) | 10.13% | 15.02% | 18.71% |
Return on Invested Capital (Normalized) | 7.63% | 10.29% | 10.97% |
Return on Assets
MKGAF
BIIB
TMO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tlsfpmvlb | Kzwg | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Chgbmjrss | Mlhdvv | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Whmfkhsr | Rtw | $41.4 Bil | |||
| Viatris Inc
VTRS
| Cczskjxk | Wvk | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Nqkwdyq | Ffpr | $13.7 Bil | |||
| Catalent Inc
CTLT
| Pnwcykhd | Dhyct | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Jrmdlgpmv | Jjbyt | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kcnvvbrbh | Lfnpn | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tgbrrjw | Bmsr | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Tcswlfmzvg | Gxfr | $2.7 Bil |